Maarit K. Leinonen

3.5k total citations · 2 hit papers
70 papers, 1.6k citations indexed

About

Maarit K. Leinonen is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Maarit K. Leinonen has authored 70 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Public Health, Environmental and Occupational Health, 28 papers in Pediatrics, Perinatology and Child Health and 21 papers in Epidemiology. Recurrent topics in Maarit K. Leinonen's work include Pregnancy and Medication Impact (25 papers), Cervical Cancer and HPV Research (17 papers) and Pharmacological Effects and Toxicity Studies (13 papers). Maarit K. Leinonen is often cited by papers focused on Pregnancy and Medication Impact (25 papers), Cervical Cancer and HPV Research (17 papers) and Pharmacological Effects and Toxicity Studies (13 papers). Maarit K. Leinonen collaborates with scholars based in Finland, Sweden and Norway. Maarit K. Leinonen's co-authors include Nea Malila, Jussi Tarkkanen, Ahti Anttila, Laura Kotaniemi‐Talonen, Mika Gissler, Pekka Nieminen, Janne Pitkäniemi, P Laurila, Joonas Miettinen and Sanna Heikkinen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Diabetes Care.

In The Last Decade

Maarit K. Leinonen

64 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability

2022 118 citations Marte‐Helene Bjørk, Helga Zoëga et al. profile →
Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy

2023 68 citations Carolyn E. Cesta, Jacqueline M. Cohen et al. profile →

Peers

Maarit K. Leinonen

EPIDE

PHEOH

PPCH

ONCOL

SURGE

Tibor Nyári Hungary

Rajesh Varma United Kingdom

H Abramovici Israel

Lynn Borgatta United States

Gaspare Cucinella Italy

Donato D’Antona Italy

Luigi Nappi Italy

Ateş Karateke Türkiye

Judy Arnon Israel

Lorenza Driul Italy

Tibor Nyári Hungary

Maarit K. Leinonen

319 ×0.5

EPIDE

240 ×0.5

PHEOH

259 ×0.6

PPCH

180 ×0.4

ONCOL

253 ×0.7

SURGE

Citations per year, relative to Maarit K. Leinonen Maarit K. Leinonen (= 1×) peers Tibor Nyári

Countries citing papers authored by Maarit K. Leinonen

Since Specialization

Citations

This map shows the geographic impact of Maarit K. Leinonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarit K. Leinonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarit K. Leinonen more than expected).

Fields of papers citing papers by Maarit K. Leinonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarit K. Leinonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarit K. Leinonen. The network helps show where Maarit K. Leinonen may publish in the future.

Co-authorship network of co-authors of Maarit K. Leinonen

This figure shows the co-authorship network connecting the top 25 collaborators of Maarit K. Leinonen. A scholar is included among the top collaborators of Maarit K. Leinonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarit K. Leinonen. Maarit K. Leinonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Given, Joanne, Rebecca Bromley, Elisa Ballardini, et al.. (2025). The Effect of Different Algorithms on Prevalence of Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder in Secondary Healthcare Data in Five European Countries: A Contribution from the ConcePTION Project. Journal of Autism and Developmental Disorders. 1 indexed citations

Heinävaara, Sirpa, Joakim Dillner, Ilkka Kalliala, et al.. (2025). Long‐term human papillomavirus genotype‐specific risk of cervical high‐grade intraepithelial lesion and cancer—By age group and triage cytology. International Journal of Cancer. 158(4). 931–941.

Dreier, Julie Werenberg, Jannicke Igland, Nils Erik Gilhus, et al.. (2024). Prescribing patterns for higher dose folic acid in pregnant women with epilepsy treated with antiseizure medication. Epilepsia. 65(6). 1698–1708. 3 indexed citations

Leinonen, Maarit K., Jannicke Igland, Julie Werenberg Dreier, et al.. (2024). Socioeconomic differences in use of antiseizure medication in pregnancies with maternal epilepsy: A population‐based study from Nordic universal health care systems. Epilepsia. 65(8). 2397–2411. 2 indexed citations

Cesta, Carolyn E., Vidar Hjellvik, Sinna Pilgaard Ulrichsen, et al.. (2024). Antipsychotic use during pregnancy and risk of specific neurodevelopmental disorders and learning difficulties in children: a multinational cohort study. EClinicalMedicine. 70. 102531–102531. 5 indexed citations

Karlsson, Pär, Anja Geldhof, Mika Gissler, et al.. (2024). Pregnancy and Infant Outcomes After Prenatal Exposure to Golimumab in Denmark, Finland, and Sweden 2006–2019. Pharmacoepidemiology and Drug Safety. 33(8). e5878–e5878. 1 indexed citations

Dreier, Julie Werenberg, Jannicke Igland, Silje Alvestad, et al.. (2024). High‐dose folic acid use and cancer risk in women who have given birth: A register‐based cohort study. Epilepsia. 66(1). 75–88. 6 indexed citations

Leinonen, Maarit K., et al.. (2023). PR098/#798 HPV screening is effective against vaginal and vulvar cancers. A85.1–A85. 1 indexed citations

Kjerpeseth, Lars J., Carolyn E. Cesta, Kari Furu, et al.. (2023). Metformin Versus Insulin and Risk of Major Congenital Malformations in Pregnancies With Type 2 Diabetes: A Nordic Register-Based Cohort Study. Diabetes Care. 46(8). 1556–1564. 11 indexed citations

10.

Ellfolk, Maria, Maarit K. Leinonen, Mika Gissler, et al.. (2021). Second-generation antipsychotic use during pregnancy and risk of congenital malformations. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations

11.

Vettenranta, Kim, et al.. (2021). Preterm birth, neonatal therapies and the risk of childhood cancer. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari).

12.

Pakkasjärvi, Niklas, Johanna Syvänen, Tuomas Tauriainen, et al.. (2021). Prune belly syndrome in Finland-A population-based study on current epidemiology and hospital admissions. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari).

13.

Hálfdánarson, Óskar, Jacqueline M. Cohen, Øystein Karlstad, et al.. (2021). Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study. Evidence-Based Mental Health. 25(2). 54–62. 17 indexed citations

14.

Cohen, Jacqueline M., Carolyn E. Cesta, Kari Furu, et al.. (2020). Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006‐2016: A study in the five Nordic countries, United States, and Australia. Pharmacoepidemiology and Drug Safety. 29(8). 913–922. 36 indexed citations

15.

Cesta, Carolyn E., Óskar Hálfdánarson, Jacqueline M. Cohen, et al.. (2020). Ssri/snri discontinuation in pregnancy and obstetrical outcomes: A nordic population register-based study. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations

16.

Raitio, Arimatias, Tuomas Tauriainen, Maarit K. Leinonen, et al.. (2020). Extended spectrum penicillins reduce the risk of omphalocele: A population-based case-control study. Journal of Pediatric Surgery. 56(9). 1590–1595. 6 indexed citations

17.

Leinonen, Maarit K., et al.. (2019). Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016. International Journal of Cancer. 145(10). 2629–2638. 34 indexed citations

18.

Cohen, Jacqueline M., Maarit K. Leinonen, Silje Alvestad, et al.. (2019). Comparative Safety of Antiepileptic Drugs and Risk of Major Congenital Malformations. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations

19.

Leinonen, Maarit K., Joonas Miettinen, Sanna Heikkinen, Janne Pitkäniemi, & Nea Malila. (2017). Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours. European Journal of Cancer. 77. 31–39. 160 indexed citations

20.

Malila, Nea, Maarit K. Leinonen, Laura Kotaniemi‐Talonen, et al.. (2012). The HPV test has similar sensitivity but more overdiagnosis than the Pap test—A randomised health services study on cervical cancer screening in Finland. International Journal of Cancer. 132(9). 2141–2147. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact